• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负载针对Bcl-2的反义寡核苷酸间隙mer的脂质纳米颗粒用于治疗肺癌。

Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.

作者信息

Cheng Xinwei, Liu Qibing, Li Hong, Kang Chen, Liu Yang, Guo Tianqi, Shang Ke, Yan Chengyun, Cheng Guang, Lee Robert J

机构信息

Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio, 43210, USA.

Department of Pharmacology, Hainan Medical University, Xueyuan Road, Haikou, 571199, Hainan, China.

出版信息

Pharm Res. 2017 Feb;34(2):310-320. doi: 10.1007/s11095-016-2063-5. Epub 2016 Nov 28.

DOI:10.1007/s11095-016-2063-5
PMID:27896589
Abstract

PURPOSE

Bcl-2 is an anti-apoptotic gene that is frequently overexpressed in human cancers. G3139 is an antisense oligonucleotide against bcl-2 that has shown limited efficacy in clinical trials. Here, we report the synthesis of a new antisense oligonucleotide containing additional chemical modifications and its delivery using nanoparticles.

METHODS

An oligonucleotide G3139-GAP was synthesized, which has 2'-O-methyl nucleotides at the 5' and 3' ends based on a "gapmer" design. Furthermore, G3139-GAP was incorporated into lipid nanoparticles (LNPs) composed of DOTAP/egg PC/cholesterol/Tween 80. The LNP-loaded G3139-GAP was evaluated in A549 lung cancer cells both in vitro and in a murine xenograft model for biological activity and therapeutic efficacy.

RESULTS

The LNPs showed excellent colloidal and serum stability, and high encapsulation efficiency for G3139-GAP. They have a mean particle diameter and zeta potential of 134 nm and 9.59 mV, respectively. G3139-GAP-LNPs efficiently downregulated bcl-2 expression in A549 cells, as shown by 40% and 83% reduction in mRNA and protein levels, respectively. Furthermore, G3139-GAP-LNPs were shown to inhibit tumor growth, prolong survival, and downregulate tumor bcl-2 expression in an A549 murine xenograft tumor model. These data indicate that G3139-GAP-LNPs have excellent anti-tumor efficacy and warrant further evaluation.

摘要

目的

Bcl-2是一种抗凋亡基因,在人类癌症中经常过度表达。G3139是一种针对bcl-2的反义寡核苷酸,在临床试验中显示出有限的疗效。在此,我们报告一种含有额外化学修饰的新型反义寡核苷酸的合成及其使用纳米颗粒的递送。

方法

合成了一种寡核苷酸G3139-GAP,基于“gapmer”设计,其5'和3'端具有2'-O-甲基核苷酸。此外,G3139-GAP被掺入由DOTAP/蛋黄卵磷脂/胆固醇/吐温80组成的脂质纳米颗粒(LNP)中。在A549肺癌细胞中对负载LNP的G3139-GAP进行体外和小鼠异种移植模型评估,以检测其生物活性和治疗效果。

结果

LNP显示出优异的胶体稳定性和血清稳定性,以及对G3139-GAP的高包封效率。它们的平均粒径和zeta电位分别为134 nm和9.59 mV。如mRNA和蛋白质水平分别降低40%和83%所示,G3139-GAP-LNP在A549细胞中有效下调bcl-2表达。此外,在A549小鼠异种移植肿瘤模型中,G3139-GAP-LNP显示出抑制肿瘤生长、延长生存期和下调肿瘤bcl-2表达的作用。这些数据表明G3139-GAP-LNP具有优异的抗肿瘤疗效,值得进一步评估。

相似文献

1
Lipid Nanoparticles Loaded with an Antisense Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung Cancer.负载针对Bcl-2的反义寡核苷酸间隙mer的脂质纳米颗粒用于治疗肺癌。
Pharm Res. 2017 Feb;34(2):310-320. doi: 10.1007/s11095-016-2063-5. Epub 2016 Nov 28.
2
T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.T7 肽偶联脂质纳米颗粒双重调控肺癌和宫颈癌中 Bcl-2 和 Akt-1。
Mol Pharm. 2018 Oct 1;15(10):4722-4732. doi: 10.1021/acs.molpharmaceut.8b00696. Epub 2018 Sep 7.
3
Antitumor activity of G3139 lipid nanoparticles (LNPs).G3139脂质纳米颗粒(LNPs)的抗肿瘤活性。
Mol Pharm. 2009 Jan-Feb;6(1):211-20. doi: 10.1021/mp800146j.
4
A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML.一种用于将反义寡核苷酸递送至急性髓系白血病细胞的含聚乙烯亚胺和转铁蛋白共轭脂质纳米颗粒系统
Biomed Res Int. 2016;2016:1287128. doi: 10.1155/2016/1287128. Epub 2016 Jan 26.
5
Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.转铁蛋白受体靶向脂质多聚体用于在小鼠K562异种移植模型中递送反义寡核苷酸g3139
Pharm Res. 2009 Jun;26(6):1516-24. doi: 10.1007/s11095-009-9864-8. Epub 2009 Mar 17.
6
Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.用于递送针对Bcl-2的反义寡脱氧核糖核苷酸的转铁蛋白受体靶向脂质纳米颗粒。
Mol Pharm. 2009 Jan-Feb;6(1):221-30. doi: 10.1021/mp800149s.
7
Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo.体外和体内研究中性胞苷脂质结合阳离子脂质包封的反义寡核苷酸 G3139 的结构优化和额外靶标鉴定。
Biomaterials. 2019 Mar;197:182-193. doi: 10.1016/j.biomaterials.2018.12.033. Epub 2019 Jan 3.
8
G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.G3139和其他含CpG的免疫刺激硫代磷酸酯寡脱氧核苷酸是裸鼠体内人肿瘤异种移植生长的有效抑制剂。
Oligonucleotides. 2006 Spring;16(1):83-93. doi: 10.1089/oli.2006.16.83.
9
Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.电穿孔增强了 bcl-2 反义 G3139 和化疗在人黑色素瘤异种移植模型中的抗肿瘤疗效。
J Transl Med. 2011 Jul 28;9:125. doi: 10.1186/1479-5876-9-125.
10
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.G3139(一种bcl-2反义寡核苷酸)联合卡铂和依托泊苷治疗小细胞肺癌的I期研究。
J Clin Oncol. 2004 Mar 15;22(6):1110-7. doi: 10.1200/JCO.2004.10.148.

引用本文的文献

1
Lipid-based Non-viral Vector: Promising Approach for Gene Delivery.基于脂质的非病毒载体:基因递送的有前景方法。
Curr Pharm Des. 2025;31(7):521-539. doi: 10.2174/0113816128324084240828084904.
2
Lipid Nanoparticles in Lung Cancer Therapy.肺癌治疗中的脂质纳米颗粒
Pharmaceutics. 2024 May 10;16(5):644. doi: 10.3390/pharmaceutics16050644.
3
Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment.非编码RNA:靶向肿瘤微环境的“敌”还是“友”

本文引用的文献

1
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.辅助脂质在用于寡核苷酸递送的脂质纳米颗粒(LNP)中的作用。
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):129-137. doi: 10.1016/j.addr.2016.01.022. Epub 2016 Feb 18.
2
A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.一种用于磁共振癌症分子成像的基于主客体自组装的靶向纳米球状造影剂。
Biomaterials. 2016 Apr;85:168-79. doi: 10.1016/j.biomaterials.2016.02.002. Epub 2016 Feb 3.
3
Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.
Noncoding RNA. 2023 Aug 28;9(5):52. doi: 10.3390/ncrna9050052.
4
The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.非小细胞肺癌中的小 RNA 全景:当前的治疗应用和进展。
Int J Mol Sci. 2023 Mar 24;24(7):6121. doi: 10.3390/ijms24076121.
5
Lipids and Lipid Derivatives for RNA Delivery.用于 RNA 递送的脂质和脂质衍生物。
Chem Rev. 2021 Oct 27;121(20):12181-12277. doi: 10.1021/acs.chemrev.1c00244. Epub 2021 Jul 19.
6
RNA-based therapies: A cog in the wheel of lung cancer defense.基于 RNA 的疗法:肺癌防御中的一个关键因素。
Mol Cancer. 2021 Mar 19;20(1):54. doi: 10.1186/s12943-021-01338-2.
7
Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals.纳米载体用于生物制药高效递送的潜力与应用
Pharmaceutics. 2020 Dec 6;12(12):1184. doi: 10.3390/pharmaceutics12121184.
8
Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy.脂质体和聚合物非病毒载体在下一代基因治疗中的核酸传递中的作用。
Molecules. 2020 Jun 22;25(12):2866. doi: 10.3390/molecules25122866.
9
Delivery of antisense oligonucleotide using polyethylenimine-based lipid nanoparticle modified with cell penetrating peptide.采用穿膜肽修饰的聚乙二醇化脂质纳米粒递呈反义寡核苷酸。
Drug Deliv. 2019 Dec;26(1):965-974. doi: 10.1080/10717544.2019.1667453.
10
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease.微小 RNA 作为一种新型工具在肝脂质失调和脂肪肝疾病诊断中的应用。
Molecules. 2019 Jan 9;24(2):230. doi: 10.3390/molecules24020230.
由季铵-叔胺阳离子脂质组合(QTsome)组成的脂质纳米颗粒用于抗miR-21治疗性递送治疗肺癌
Mol Pharm. 2016 Feb 1;13(2):653-62. doi: 10.1021/acs.molpharmaceut.5b00878. Epub 2016 Jan 19.
4
Clinical and preclinical pharmacokinetics and pharmacodynamics of mipomersen (kynamro(®)): a second-generation antisense oligonucleotide inhibitor of apolipoprotein B.米泊美生(Kynamro®)的临床和临床前药代动力学及药效学:一种第二代载脂蛋白B反义寡核苷酸抑制剂
Clin Pharmacokinet. 2015 Feb;54(2):133-46. doi: 10.1007/s40262-014-0224-4.
5
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells.阿托伐他汀克服 KRAS 突变型人非小细胞肺癌细胞中的吉非替尼耐药性。
Cell Death Dis. 2013 Sep 26;4(9):e814. doi: 10.1038/cddis.2013.312.
6
Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animals.脂质纳米颗粒可提高单链小干扰RNA和缺口mer反义寡核苷酸在动物体内的活性。
ACS Chem Biol. 2013 Jul 19;8(7):1402-6. doi: 10.1021/cb4001316. Epub 2013 May 2.
7
Designing chemically modified oligonucleotides for targeted gene silencing.设计用于靶向基因沉默的化学修饰寡核苷酸。
Chem Biol. 2012 Aug 24;19(8):937-54. doi: 10.1016/j.chembiol.2012.07.011.
8
Current progress of siRNA/shRNA therapeutics in clinical trials.siRNA/shRNA 治疗药物在临床试验中的当前进展。
Biotechnol J. 2011 Sep;6(9):1130-46. doi: 10.1002/biot.201100054. Epub 2011 Jul 11.
9
Adsorbed Tween 80 is unique in its ability to improve the stability of gold nanoparticles in solutions of biomolecules.吸附的吐温 80 具有独特的能力,可以提高生物分子溶液中纳米金的稳定性。
Nanoscale. 2010 Oct;2(10):2114-9. doi: 10.1039/c0nr00309c. Epub 2010 Aug 9.
10
A locked nucleic acid antisense oligonucleotide (LNA) silences PCSK9 and enhances LDLR expression in vitro and in vivo.一种锁核酸反义寡核苷酸(LNA)可在体外和体内沉默 PCSK9 并增强 LDLR 的表达。
PLoS One. 2010 May 17;5(5):e10682. doi: 10.1371/journal.pone.0010682.